The bicinchoninic acid (BCA) assay is one of the most widely used methods for measuring total protein concentration in a sample, valued for its sensitivity, tolerance of common lab chemicals, and straightforward one-step workflow. First described in 1985, it works by detecting the copper ions that proteins reduce in alkaline solution, producing a purple color whose intensity scales with the amount of protein present. The assay is a staple across biochemistry, pharmaceutical development, and food science, but it comes with quirks and blind spots that matter in practice.
How the BCA Assay Works
The assay relies on two linked reactions. In the first step, proteins in the sample reduce cupric ions (Cu²⁺) to cuprous ions (Cu⁺) in an alkaline environment. Certain amino acid side chains drive this reduction: cysteine, cystine, tryptophan, and tyrosine all contribute, along with the peptide bonds that link amino acids together in every protein chain.1Analytical Biochemistry. Investigation of the bicinchoninic acid protein assay: Identification of the groups responsible for color formation In the second step, two molecules of bicinchoninic acid chelate each cuprous ion, forming a purple-colored complex that absorbs light strongly at 562 nm. The more protein in the sample, the more Cu⁺ is generated, and the deeper the purple color becomes.
You measure the intensity of that color using a spectrophotometer or plate reader, then compare it against a standard curve built from known concentrations of a reference protein, usually bovine serum albumin (BSA). The relationship between protein concentration and absorbance is roughly linear across a useful working range, though at very high protein levels the curve flattens and eventually dips. Research into why this happens points to competition: at high concentrations, the protein’s peptide bonds start competing directly with BCA molecules for binding to cuprous ions, which starves the color-forming reaction of the copper it needs.2PubMed Central. Competitive Binding to Cuprous Ions of Protein and BCA in the Bicinchoninic Acid Protein Assay
Why It Became So Popular
Before the BCA assay came along, the Lowry method was the go-to approach for protein quantification. The Lowry assay works, but it is sensitive to interference from detergents, buffer salts, and other chemicals that are routine in protein sample preparation. When Paul Smith and colleagues introduced the BCA assay, they showed it tolerated nonionic detergents and common buffer salts far better than the Lowry method, while matching its sensitivity and producing low protein-to-protein variation.3PubMed. Measurement of protein using bicinchoninic acid Just as important, the BCA assay simplified the workflow. The Lowry method involves multiple reagent additions and timed steps; the BCA assay is essentially a single mix-and-incubate procedure. That practical advantage made adoption fast and broad.
Compared to the Bradford assay, another common alternative based on Coomassie dye binding, the BCA assay tends to show less variation between different proteins. When several protein quantification methods were compared head-to-head against amino acid analysis as a gold standard, the BCA assay displayed some of the lowest variability across different proteins and produced better estimates when BSA was used as the standard.4PubMed. A comparison of protein quantitation assays for biopharmaceutical applications That consistency matters because in most real experiments you do not have a purified standard of your exact target protein, so you are comparing against BSA or another surrogate and hoping the relationship holds.
Incubation Time and Flexibility
The standard protocol calls for incubating the sample with BCA reagent at 37 °C for 30 minutes. Many researchers follow that timing without questioning it. But the reaction kinetics are more forgiving than the protocol implies. A detailed study of BCA kinetics found that although the underlying chemistry is complex, the ratio of absorbance to protein concentration remains stable across different incubation times, as long as the absorbance at 562 nm exceeds about 0.1. The practical upshot is that you can run the assay with incubation times as short as 15 minutes and still get reliable results.5Analytical Biochemistry. Protein quantification by bicinchoninic acid (BCA) assay follows complex kinetics and can be performed at short incubation times That flexibility is genuinely useful when you are processing dozens of samples and do not want to wait longer than necessary.
There are also enhanced-sensitivity protocols that use a higher incubation temperature (60 °C) for a shorter time, shifting the working range down to detect lower protein concentrations. Commercial kit manufacturers offer both “standard” and “enhanced” protocols for this reason, and the choice depends on how dilute your samples are.
What Interferes With the Assay
The BCA assay is more tolerant of lab chemicals than the Lowry method, but it is not immune to interference.6Analytical Biochemistry. Protein measurement using bicinchoninic acid: elimination of interfering substances The main troublemakers fall into a few categories.
Reducing agents are the most common headache. Chemicals like dithiothreitol (DTT), beta-mercaptoethanol, and TCEP are used routinely to break disulfide bonds in proteins, and they also reduce Cu²⁺ to Cu⁺ all on their own. That means your blank sample lights up purple even without any protein, inflating your readings. One practical workaround involves pre-treating samples with a compatibility reagent that neutralizes the reducing agent before you add the BCA reagent.7The FASEB Journal. Development of a Detergent and Reducing Agent Compatible BCA Protein Assay
Certain sugars and polysaccharides also interfere. In pharmaceutical formulations where dextran is used as an excipient, for example, the standard BCA assay gives erroneous protein readings. Modified BCA protocols and alternative techniques like reversed-phase HPLC have been developed specifically to get around this problem.8Journal of Pharmaceutical and Biomedical Analysis. Development and evaluation of new methods for protein quantification in dissolving microneedles formulations
Lipids and certain chelating agents can also skew results. And because the color reaction depends partly on specific amino acids like cysteine and tryptophan, substances with similar functional groups produce background signal that cannot simply be subtracted by running a reagent blank.9Analytical Biochemistry. Investigation of the bicinchoninic acid protein assay: Identification of the groups responsible for color formation The practical lesson is that you need to know what else is in your sample buffer and check whether it falls on the list of known interferents before trusting your numbers.
The Protein-to-Protein Variation Problem
Every colorimetric protein assay shares a fundamental limitation: different proteins produce different amounts of signal per microgram. In the BCA assay, the color depends on how many reactive amino acid residues a protein contains and how accessible they are. A protein rich in cysteine and tryptophan will generate more Cu⁺ than a protein of the same mass but with fewer of those residues. Since you typically calibrate against BSA, your reported concentration is really “BSA equivalents” rather than a true mass measurement.
The BCA assay handles this problem better than most alternatives because a significant portion of its signal comes from the peptide bond itself, which every protein has in abundance regardless of its amino acid composition. That is why the assay shows lower protein-to-protein variation than dye-binding methods like Bradford. But the variation is not zero. For applications where absolute accuracy matters, you either need a standard that closely matches your target protein or you need to calibrate against a technique like amino acid analysis that measures protein mass directly.
Accuracy at Low Concentrations
Researchers who work at the bottom of the assay’s detection range have long noticed that accuracy suffers with very dilute samples. A recent investigation into this issue found systematic biases in the standard microplate BCA protocol at low protein concentrations and proposed a two-step incubation and calibration approach to fix it. The method adds a modest amount of extra work but eliminates the biases that plague the standard wide-range protocol when protein levels are low.10PubMed. Pandora box of BCA assay. Investigation of the accuracy and linearity of the microplate bicinchoninic protein assay: Analytical challenges and method modifications to minimize systematic errors
If you regularly quantify dilute samples, it is worth considering whether the standard 30-minute, 37 °C protocol is giving you trustworthy numbers or whether switching to the enhanced protocol or the two-step calibration approach would improve your data. Many labs run a quick BCA and move on without ever validating their low-end measurements, which can quietly introduce errors into downstream experiments.
Where the BCA Assay Struggles Against Alternatives
The BCA assay is not always the best choice. A comparative study that tested it alongside the Bradford assay and the Dumas combustion method for quantifying protein in milk from different species found that BCA values were significantly different from the reference Kjeldahl method, while Bradford and Dumas agreed with Kjeldahl more closely.11PubMed Central. Comparative study of the most commonly used methods for total protein determination in milk of different species and their ultrafiltration products Milk is a complex matrix with fats, sugars, and diverse protein types, and this combination apparently trips up the BCA chemistry enough to throw off the results.
For complex food and environmental samples, a broader comparison of methods including amino acid analysis, liquid chromatography, and colorimetric assays confirmed that all these techniques work reasonably well under controlled conditions, but results for non-standard and complex samples are often questionable.12PubMed Central. Determination of the protein content of complex samples by aromatic amino acid analysis, liquid chromatography-UV absorbance, and colorimetry The BCA assay is no exception. If your sample has a lot of non-protein components that interact with copper chemistry, you should validate against an orthogonal method before committing to BCA as your routine approach.
Glycosylated proteins are an interesting edge case. Despite the general caution about modifications affecting assay accuracy, one study comparing quantification methods for enriched glycoproteins from mouse muscle found that BCA was actually the most reliable option for those samples.13PubMed. Quantification, 2DE analysis and identification of enriched glycosylated proteins from mouse muscles: Difficulties and alternatives This fits the general pattern: the BCA assay’s reliance on the peptide bond for a large share of its signal makes it relatively resistant to the effects of post-translational modifications, though glycosylation and PEGylation can still shift readings for certain assays in biopharmaceutical contexts.14PubMed. A comparison of protein quantitation assays for biopharmaceutical applications
Automation and High-Throughput Workflows
Modern proteomics and drug development labs often need to quantify protein in dozens or hundreds of samples at once. The BCA assay adapts well to automation because it is a single-reagent, single-incubation protocol that runs easily in 96-well microplates. Automated workflows using liquid-handling robots have been shown to match or outperform manual pipetting in accuracy. One platform designed for proteomics sample preparation reported an average protein recovery of about 101% with the automated BCA workflow, compared to roughly 96% for manual handling, with the automated approach also producing tighter consistency across replicates.15PubMed. MassSpecPreppy-An end-to-end solution for automated protein concentration determination and flexible sample digestion for proteomics applications
Even without a full liquid-handling robot, simpler automation options exist. One group demonstrated that a standard desktop flatbed scanner can replace a plate reader for reading BCA assay results, with the image-based measurements correlating extremely well with conventional absorbance readings.16Biomedicine. Sensitive and rapid Bradford and BCA protein assay by a common desktop scanner That approach opens up BCA quantification for labs that lack expensive plate readers, though it does require some software to extract and calibrate color intensity from the scanned images.
Applications in Nanotechnology
One area where the BCA assay has become especially important is in characterizing the protein corona that forms on nanoparticles when they enter biological fluids. When nanoparticles are introduced into blood or cell culture media, proteins rapidly adsorb onto their surface, forming a coating that fundamentally changes how cells interact with the particle. Understanding this coating is critical for drug delivery, toxicology, and diagnostic applications.
Researchers use the BCA assay to quantify the total mass of protein adsorbed per nanoparticle, which then feeds into calculations of how many copies of each protein are present on the surface.17PubMed Central. Mapping and identification of soft corona proteins at nanoparticles and their impact on cellular association The BCA measurement typically serves as the first step in a workflow: measure total protein mass by BCA, then identify which specific proteins are present using mass spectrometry. This combination of a quick bulk measurement followed by detailed identification has made BCA a standard tool in the nanoparticle characterization pipeline.18Chem Bio Eng. Protein Corona of Nanoparticles: Isolation and Analysis
Pharmaceutical Formulation and Drug Delivery
In drug development, protein-based therapeutics need to be quantified at every stage, from formulation to quality control. The BCA assay is commonly used to measure how much protein has been loaded into delivery vehicles like biodegradable microspheres. Studies of protein-loaded PLG microspheres, for instance, have used BCA measurements to show that protein loading efficiency increases with microsphere size.19PubMed. Measuring the heterogeneity of protein loading in PLG microspheres using flow cytometry
The challenge in pharmaceutical work is that formulations often contain excipients, stabilizers, and polymers that can interfere with the assay. The dextran interference mentioned earlier is one example. When the standard BCA protocol fails, labs develop modified versions specific to their formulation, or they validate BCA results against chromatographic methods to make sure the numbers hold up.20Journal of Pharmaceutical and Biomedical Analysis. Development and evaluation of new methods for protein quantification in dissolving microneedles formulations The broader pattern is that BCA works well as a first-line tool but requires cross-validation whenever the sample matrix departs from a simple buffered protein solution.
Practical Tips for Getting Reliable Results
If you run BCA assays regularly, a few habits separate reliable data from numbers that look plausible but quietly mislead you.
- Match your standard to your sample: BSA is the default, but if your sample is heavily glycosylated, membrane-rich, or otherwise unusual in composition, consider running a second standard curve with a protein closer to your target. The protein-to-protein variation in BCA is smaller than in Bradford, but it is not negligible.
- Run buffer-only blanks that contain everything except protein: If your lysis buffer has a reducing agent or detergent, your blank must too. Subtracting a water-only blank will not correct for the background signal those additives produce.
- Stay in the linear range: Dilute concentrated samples rather than reading them on the flat portion of the standard curve. The nonlinear region is not just slightly less accurate; the competitive binding effect means absorbance can actually decrease as you add more protein, which would invert your concentration estimate.
- Be skeptical of low-end readings: If your absorbance values are close to the blank, the standard wide-range protocol may not be accurate enough. Switch to the enhanced protocol or consider the two-step calibration approach.
- Control your incubation temperature: The reaction rate is temperature-dependent. Plate edges cool faster than plate centers in an incubator, which can create systematic differences across a 96-well plate. Pre-warming reagents and using a plate sealer helps reduce edge effects.
None of these steps is complicated, but skipping them is how labs end up with protein concentration values that are off by 20 to 30 percent without anyone noticing until something downstream fails to work.
Low-Cost and Field-Adapted Formats
The conventional BCA workflow requires a spectrophotometer or microplate reader, which limits where the assay can be performed. The scanner-based reading method mentioned earlier represents one effort to lower that barrier. By photographing the developed plate on a flatbed scanner and analyzing pixel color intensities, researchers obtained BCA standard curves with Pearson correlation coefficients above 0.99 compared to conventional absorbance readings.21Biomedicine. Sensitive and rapid Bradford and BCA protein assay by a common desktop scanner Smartphone-based approaches using similar image-analysis logic are also being explored for field and point-of-care settings where traditional lab instruments are unavailable. These adaptations do not change the underlying chemistry; they simply replace the detector. The BCA reaction’s strong purple color makes it particularly well suited to visual and camera-based readouts compared to assays that produce subtler color shifts.